Geron (GERN) Completes Embryonic Stem Cell Asset Divestiture – StreetInsider.com (subscription)
|
Geron (GERN) Completes Embryonic Stem Cell Asset Divestiture
StreetInsider.com (subscription) On October 1, 2013, Geron Corporation (Nasdaq: GERN) announced the closing of the transaction to divest the Company’s human embryonic stem cell assets pursuant to the terms of the previously disclosed Asset Contribution Agreement, dated as of … |
